Universe Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Universe Pharmaceuticals has a total shareholder equity of $39.5M and total debt of $5.5M, which brings its debt-to-equity ratio to 13.9%. Its total assets and total liabilities are $53.3M and $13.8M respectively.
Key information
13.9%
Debt to equity ratio
US$5.48m
Debt
| Interest coverage ratio | n/a |
| Cash | US$18.50m |
| Equity | US$39.53m |
| Total liabilities | US$13.75m |
| Total assets | US$53.29m |
Recent financial health updates
Recent updates
Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry
Apr 07
Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%
Feb 07There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise
Dec 18Universe pharmaceuticals receives Nasdaq notification regarding minimum bid price deficiency
Jul 19Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet
Feb 21We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings
Aug 10Financial Position Analysis
Short Term Liabilities: UPC's short term assets ($36.8M) exceed its short term liabilities ($13.8M).
Long Term Liabilities: UPC has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: UPC has more cash than its total debt.
Reducing Debt: UPC's debt to equity ratio has reduced from 27.1% to 13.9% over the past 5 years.
Debt Coverage: UPC's debt is well covered by operating cash flow (20.4%).
Interest Coverage: Insufficient data to determine if UPC's interest payments on its debt are well covered by EBIT.